Neumora Therapeutics logo

Neumora Therapeutics Share Price (NASDAQ: NMRA)

$1.61

-0.01

(-0.62%)

Live

Last updated on

Check the interactive Neumora Therapeutics Stock chart to analyse performance

Neumora Therapeutics stock performance

as on August 26, 2025 at 12:36 AM IST

  • Today's Low:$1.61
    Today's High:$1.66

    Day's Volatility :3.01%

  • 52 Weeks Low:$0.61
    52 Weeks High:$17.19

    52 Weeks Volatility :96.45%

Neumora Therapeutics Stock Returns

PeriodNeumora Therapeutics, Inc.Index (Russel 2000)
3 Months
131.63%
0.0%
6 Months
-5.26%
0.0%
1 Year
-86.17%
0.0%
3 Years
-90.03%
-10.0%

Neumora Therapeutics, Inc. Key Stats

Check Neumora Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$1.62
Open
$1.65
Today's High
$1.66
Today's Low
$1.61
Market Capitalization
$262.4M
Today's Volume
$338.8K
52 Week High
$17.1874
52 Week Low
$0.611
Revenue TTM
$0.0
EBITDA
$-264.1M
Earnings Per Share (EPS)
$-1.57
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-89.37%

Stock Returns calculator for Neumora Therapeutics Stock including INR - Dollar returns

The Neumora Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Neumora Therapeutics investment value today

Current value as on today

₹18,104

Returns

₹81,896

(-81.9%)

Returns from Neumora Therapeutics Stock

₹86,251 (-86.25%)

Dollar Returns*

₹4,355 (+4.36%)

Indian investors sentiment towards Neumora Therapeutics Stock

48.84%

Period: Jul 26, 2025 to Aug 25, 2025. Change in 30 Days versus previous period

Investment in Neumora Therapeutics Shares from India has grown by 48.84% over the past 30 days, indicating increased transactional activity.

-5%

Period: Jul 26, 2025 to Aug 25, 2025. Change in 30 Days versus previous period

Search interest for Neumora Therapeutics Stock from India on INDmoney has decreased by -5% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Neumora Therapeutics Stock

Rating
Trend

Buy

    91%Buy

    8%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Neumora Therapeutics(by analysts ranked 0 to 5 stars)

Neumora Therapeutics Share Price Target

What analysts predicted

Upside of 275.98%

Target:

$6.05

Current:

$1.61

Neumora Therapeutics share price target is $6.05, a slight Upside of 275.98% compared to current price of $1.61 as per analysts' prediction.

Neumora Therapeutics Stock Insights

  • Price Movement

    In the last 1 month, NMRA stock has moved down by -31.1%
  • NMRA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.7% return, outperforming this stock by 152.8%

Neumora Therapeutics Technicals Summary

Sell

Neutral

Buy

Neumora Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Neumora Therapeutics, Inc. Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Neumora Therapeutics, Inc. logo
-28.95%
-5.26%
-86.17%
-90.03%
-90.03%
Regeneron Pharmaceuticals, Inc. logo
5.52%
-17.35%
-50.85%
-1.12%
-3.68%
Beone Medicines Ltd logo
6.51%
21.35%
57.45%
73.21%
25.84%
Vertex Pharmaceuticals Incorporated logo
-14.26%
-17.97%
-18.13%
40.27%
45.64%
Alnylam Pharmaceuticals, Inc. logo
39.9%
82.53%
68.83%
115.41%
241.51%

About Neumora Therapeutics, Inc.

Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases in the United States. The company develops navacaprant (NMRA-140), a novel once-daily oral kappa opioid receptor antagonist, which is in phase 3 clinical trials for the treatment of major depressive disorder. It also develops NMRA-511 that is in phase 1 clinical trials in patients with agitation associated with dementia due to Alzheimer's disease. In addition, the company's preclinical phase product includes NMRA-NMDA and NMRA-M4R for the treatment of Schizophrenia; NMRA-CK1d, a CK1d inhibitor program for the treatment of amyotrophic lateral sclerosis; NMRA-NLRP3 for the treatment of certain neurodegenerative conditions; and NMRA-GCase for the treatment of Parkinson's disease. The company was formerly known as RBNC Therapeutics, Inc. and changed its name to Neumora Therapeutics, Inc. in October 2021. Neumora Therapeutics, Inc. was incorporated in 2019 and is headquartered in Watertown, Massachusetts.
Organization
Neumora Therapeutics
Employees
96
CEO
Dr. Daljit Singh Aurora Pharm.D.
Industry
Miscellaneous

Key Management of Neumora Therapeutics, Inc.

NameTitle
Dr. Daljit Singh Aurora Pharm.D.
Chief Operationg & Development officer
Dr. Joshua Pinto Ph.D.
President
Mr. Michael Lee Milligan
CFO & Principal Accounting Officer
Dr. Rajesh Manchanda Ph.D.
Chief Technical Operations Officer
Dr. Nicholas Brandon Ph.D.
Chief Scientific Officer
Mr. Jason G. Duncan J.D.
Chief Legal & Administrative Officer
Helen Rubinstein
Head of Investor Relations
Ms. Amy Sullivan
Chief Human Resources Officer
Ms. Lori Houle
Chief Quality Officer
Dr. Maryjo Chamberlain-Tharp Ph.D.
Chief Business Officer

Important FAQs about investing in NMRA Stock from India :

What is Neumora Therapeutics share price today?

Neumora Therapeutics share price today is $1.61 as on . Neumora Therapeutics share today touched a day high of $1.66 and a low of $1.61.

What is the 52 week high and 52 week low for Neumora Therapeutics share?

Neumora Therapeutics share touched a 52 week high of $17.19 and a 52 week low of $0.61. Neumora Therapeutics stock price today i.e. is trending at $1.61, lower by 90.63% versus the 52 week high.

How to invest in Neumora Therapeutics Stock (NMRA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Neumora Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Neumora Therapeutics Shares that will get you 0.9317 shares as per Neumora Therapeutics share price of $1.61 per share as on August 26, 2025 at 12:36 AM IST.

What is the minimum amount required to buy Neumora Therapeutics Stock (NMRA) from India?

Indian investors can start investing in Neumora Therapeutics (NMRA) shares with as little as ₹87.554 or $1 (as of August 26, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.54 in Neumora Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 26, 2025). Based on Neumora Therapeutics share’s latest price of $1.61 as on August 26, 2025 at 12:36 AM IST, you will get 6.2112 shares of Neumora Therapeutics. Learn more about fractional shares .

What are the returns that Neumora Therapeutics has given to Indian investors in the last 5 years?

Neumora Therapeutics stock has given -90.03% share price returns and 18.05% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?